Literature DB >> 11505216

Haemodynamic characterization of young normotensive men carrying the 825T-allele of the G-protein beta3 subunit.

R F Schäfers1, J Nürnberger, A Rütz, W Siffert, R R Wenzel, A Mitchell, T Philipp, M C Michel.   

Abstract

A C825T polymorphism was recently identified in the gene for the G-protein beta3 subunit, the T-allele being associated with hypertension. To better understand the underlying pathophysiological mechanisms, we compared the haemodynamics of young healthy males with and without the T-allele. In three studies, subjects were investigated with regard to cardiac and vascular function at rest and following intravenous administration of the beta-adrenoceptor antagonist, propranolol, and the alpha2-adrenoceptor agonist, alpha-methylnoradrenaline, and with regard to local venous vasoconstriction in the dorsal hand vein in situ following infusion of the alpha2-adrenoceptor agonist, azepexol. alpha2-Adrenoceptor agonists were chosen as vasoconstrictor drugs since alpha2-adrenoceptors couple to pertussis toxin (PTX)-sensitive G-proteins and since in-vitro studies have demonstrated enhanced signal transduction of PTX-dependent pathways in the presence of the T-allele. Total peripheral resistance was determined as a parameter of vasoconstrictor tone and heart rate, stroke volume and systolic time intervals for cardiac function. T-allele carriers had a significantly elevated stroke volume and lower total peripheral resistance at baseline. After propranolol, their fall in stroke volume was significantly greater. During alpha-methylnoradrenaline infusion, elevation of total peripheral resistance was not increased relative to controls. Similarly, the constriction response of the dorsal hand vein to azepexol was not different. Our study does not support the idea of increased vasoconstrictor tone in T-allele carriers either at rest or during stimulation of alpha2-adrenoceptors. However, this allele may be associated with elevated cardiac stroke volume.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11505216     DOI: 10.1097/00008571-200108000-00001

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  5 in total

1.  β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant.

Authors:  Marcus Dörr; Carsten O Schmidt; Thomas Spielhagen; Alexa Bornhorst; Katharina Hentschel; Christina Franz; Klaus Empen; Thomas Kocher; Scott R Diehl; Heyo K Kroemer; Henry Völzke; Ralf Ewert; Stephan B Felix; Dieter Rosskopf
Journal:  Pharmacogenomics       Date:  2010-09       Impact factor: 2.533

2.  Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit.

Authors:  Dieter Rosskopf; Iris Manthey; Christiane Habich; Marzena Kielbik; Andreas Eisenhardt; Christiane Nikula; Melanie Urban; Stefanie Kohnen; Eva Graf; Ursula Ravens; Winfried Siffert
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

3.  G protein polymorphisms do not predict weight loss and improvement of hypertension in severely obese patients.

Authors:  Natascha Potoczna; Maria Wertli; Rudolph Steffen; Thomas Ricklin; Klaus-Ulrich Lentes; Fritz F Horber
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

Review 4.  G-protein beta3 subunit 825T allele and hypertension.

Authors:  Winfried Siffert
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

5.  Metabolic and haemodynamic effects of oral glucose loading in young healthy men carrying the 825T-allele of the G protein beta3 subunit.

Authors:  Jens Nürnberger; Sandra Dammer; Thomas Philipp; Rene R Wenzel; Rafael F Schäfers
Journal:  Cardiovasc Diabetol       Date:  2003-06-25       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.